Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 2, 2011, Pages 320-327

  Gratieri, Taís ^a   Gelfuso, Guilherme Martins ^a   De Freitas, Osvaldo ^a   Rocha, Eduardo Melani ^a   Lopez, Renata F V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; FLUCONAZOLE; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; DRUG PENETRATION; EX VIVO STUDY; IN VITRO STUDY; KERATOMYCOSIS; MICRODIALYSIS; NONHUMAN; RABBIT; SUSTAINED RELEASE FORMULATION; SWINE;

EID: 80055017990     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.05.006     Document Type: Article

References (45)

1. P.K. Shukla, M. Kumar, G.B. Keshava, Mycotic keratitis: an overview of diagnosis and therapy, Mycoses 51 (2008) 183-199. (Pubitemid 351502578)
2. A. Panda, G. Satpathy, N. Nayak, S. Kumar, A. Kumar, Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre, Clin. Exp. Ophthalmol. 35 (2007) 44-50. (Pubitemid 46195927)
3. S. Krishnan, E.K. Manavathu, P.H. Chandrasekar, Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance, Mycoses 52 (2009) 206-222.
4. A. Patel, K. Hammersmith, Contact lens-related microbial keratitis: recent outbreaks, Curr. Opin. Ophthalmol. 19 (2008) 302-306.
5. N.V. FlorCruz, I. Peczon, Medical interventions for fungal keratitis, Cochrane Database of Syst. Rev. (2008), doi:10.1002/14651858.CD004241.pub2. (Pubitemid 351807613)
6. S. Yilmaz, M. Ture, A. Maden, Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis, Cornea 26 (2007) 398-402. (Pubitemid 46684377)
7. X.Y. Yuan, K.R. Wilhelmus, A.Y. Matoba, G. Alexandrakis, D. Miller, A.J.W. Huang, Pathogenesis and outcome of Paecilomyces keratitis, Am. J. Ophthalmol. 147 (2009) 691-696.
8. S.E. Ti, A. Scott, P. Janardhanan, D.T.H. Tan, Therapeutic keratoplasty for advanced suppurative keratitis, Am. J. Ophthalmol. 143 (2007) 755-762.
9. M. Banitt, A. Berenbom, M. Shah, D. Buxton, T. Milman, A case of polymicrobial keratitis violating an intact lens capsule, Cornea 27 (2008) 1057-1061.
10. G. Bashir, W. Hussain, A. Rizvi, Bipolaris hawaiiensis keratomycosis and endophthalmitis, Mycopathologia 167 (2009) 51-53.
11. N.M. Davies, Biopharmaceutical considerations in topical ocular drug delivery, Clin. Exp. Pharmacol. Physiol. 27 (2000) 558-562. (Pubitemid 30418006)
12. H. Sasaki, K. Yamamura, T. Mukai, K. Nishida, J. Nakamura, M. Nakashima, M. Ichikawa, Enhancement of ocular drug penetration, Crit. Rev. Ther. Drug Carrier Syst. 16 (1999) 85-146. (Pubitemid 29144641)
13. B.K. Nanjawade, F.V. Manvi, A.S. Manjappa, In situ-forming hydrogels for sustained ophthalmic drug delivery, J. Control. Release. 122 (2007) 119-134. (Pubitemid 47361409)
14. S. Collaud, Q.A. Peng, R. Gurny, N. Lange, Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix, J. Pharm. Sci. 97 (2008) 2680-2690.
15. J. Hartikka, A. Geall, V. Bozoukova, D. Kurniadi, D. Rusalov, J. Enas, J.H. Yi, A. Nanci, A. Rolland, Physical characterization and in vivo evaluation of poloxamer-based DNA vaccine formulations, J. Gene Med. 10 (2008) 770-782. (Pubitemid 352003920)
16. D.S. Jones, M.L. Bruschi, O. De Freitas, M.P.D. Gremiao, E.H.G. Lara, G.P. Andrews, Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity, Int. J. Pharm. 372 (2009) 49-58.
17. L. Mayo, F. Quaglia, A. Borzacchiello, L. Ambrosio, M.I. La Rotonda, A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties, Eur. J. Pharm. Biopharm. 70 (2008) 199-206.
18. Y.X. Wang, Y.B. Tan, X.L. Huang, Y.J. Che, X. Du, Synthesis of biodegradable amphiphilic thermo-responsive multiblock polycarbonate and its selfaggregation behavior in aqueous solution, J. Appl. Polym. Sci. 112 (2009) 1425-1435.
19. J. Juhasz, V. Lenaerts, P. Raymond, H. Ong, Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels, Biomaterials 10 (1989) 265-268. (Pubitemid 19142726)
20. A.H. El Kamel, In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate, Int. J. Pharm. 241 (2002) 47-55.
21. T. Gratieri, G.M. Gelfuso, E.M. Rocha, V.H. Sarmento, O. De Freitas, R.F.V. Lopez, A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery, Eur. J. Pharm. Biopharm. 75 (2010) 186-193.
22. A.E. de Salamanca, Y. Diebold, M. Calonge, C. Garcia-Vazquez, S. Callejo, A. Vila, M.J. Alonso, Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance, Invest. Ophthalmol. Vis. Sci. 47 (2006) 1416-1425. (Pubitemid 46780748)
23. L.B. Rodrigues, H.F. Leite, M.I. Yoshida, J.B. Saliba, A.S. Cunha, A.A.G. Faraco, In vitro release and characterization of chitosan films as dexamethasone carrier, Int. J. Pharm. 368 (2009) 1-6.
24. M.J. Alonso, A. Sanchez, The potential of chitosan in ocular drug delivery, J. Pharm. Pharmacol. 55 (2003) 1451-1463. (Pubitemid 37441350)
25. C.M. Lehr, J.A. Bouwstra, E.H. Schacht, H.E. Junginger, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm. 78 (1992) 43-48.
26. A. Makhlof, M. Werle, H. Takeuchi, Mucoadhesive drug carriers and polymers for effective drug delivery, J. Drug Deliv. Sci. Technol. 18 (2008) 375-386.
27. O. Felt, P. Furrer, J.M. Mayer, B. Plazonnet, P. Buri, R. Gurny, Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention, Int. J. Pharm. 180 (1999) 185-193. (Pubitemid 29238202)
28. E.Y. Tu, Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin, Cornea 28 (2009) 116-119.
29. A.M. Avunduk, R.W. Beuerman, E.D. Warnel, H.E. Kaufman, D. Greer, Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis, Curr. Eye Res. 26 (2003) 113-117. (Pubitemid 36776118)
30. S. Yilmaz, A. Maden, Severe fungal keratitis treated with subconjunctival fluconazole, Am. J. Ophthalmol. 140 (2005) 454-458.
31. W.I. Higuchi, Analysis of data on medicament release from ointments, J. Pharm. Sci. 51 (1962) 802-804.
32. D.C. de Santana, T.T. Pupo, M.G. Sauaia, R.S. da Silva, R.F.V. Lopez, Nitric oxide photorelease from hydrogels and from skin containing a nitro-ruthenium complex, Int. J. Pharm. 391 (2010) 21-28.
33. T. Gratieri, G.M. Gelfuso, J.A. Thomazini, R.F. Lopez, Excised porcine cornea integrity evaluation in an in vitro model of iontophoretic ocular research, Ophthal. Res. 43 (2010) 208-216.
34. S. Macha, A.K. Mitra, Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique, Exp. Eye Res. 72 (2001) 289-299. (Pubitemid 32977982)
35. K.D. Rittenhouse, R.L. Peiffer Jr., G.M. Pollack, Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition, J. Pharm. Biomed. Anal. 16 (1998) 951-959. (Pubitemid 28139032)
36. R.H. Guy, J. Hadgraft, On the determination of drug release rates from topical dosage forms, Int. J. Pharm. 60 (1990) R1-R3. (Pubitemid 20171030)
37. T. Moore, S. Croy, S. Mallapragada, N. Pandit, Experimental investigation and mathematical modeling of Pluronic F127 gel dissolution: drug release in stirred systems, J. Control. Release 67 (2000) 191-202. (Pubitemid 30303834)
38. B.C. Anderson, N.K. Pandit, S.K. Mallapragada, Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels, J. Control. Release 70 (2001) 157-167. (Pubitemid 32144800)
39. H. Suh, H.W. Jun, Physicochemical and release studies of naproxen in poloxamer gels, Int. J. Pharm. 129 (1996) 13-20. (Pubitemid 26098732)
40. N.A. Peppas, P. Bures, W. Leobandung, H. Ichikawa, Hydrogels in pharmaceutical formulations, Eur. J. Pharm. Biopharm. 50 (2000) 27-46. (Pubitemid 30326687)
41. V. Dodane, M.A. Khan, J.R. Merwin, Effect of chitosan on epithelial permeability and structure, Int. J. Pharm. 182 (1999) 21-32. (Pubitemid 29229791)
42. A.F. Kotze, B.J. de Leeuw, H.L. Luessen, A.G. de Boer, J.C. Verhoef, H.E. Junginger, Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers, Int. J. Pharm. 159 (1997) 243-253. (Pubitemid 28055860)
43. H.L. Luessen, C.O. Rentel, A.F. Kotze, C.M. Lehr, A.G. deBoer, J.C. Verhoef, H.E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. 4. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro, J. Control. Release 45 (1997) 15-23. (Pubitemid 27055788)
44. G. Wei, P.T. Ding, J.M. Zheng, W.Y. Lu, Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels, Biomed. Chromatogr. 20 (2006) 67-71. (Pubitemid 43148625)
45. K.D. Rittenhouse, G.M. Pollack, Microdialysis and drug delivery to the eye, Adv. Drug Deliv. Rev. 45 (2000) 229-241.